EDP-24

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameEDP-24

Drug Alias NamePABA analog (New York University/BioLineRx)EDP-24

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA repair pathway modulators

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNew York University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiolinerx Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A